Connection

Robert Malcolm to Female

Back to Details
This is a "connection" page, showing publications Robert Malcolm has written about Female.
Robert Malcolm
Connection Strength
0.636
Female
  1. Comparative Ethanol-Induced Potentiation of Stimulatory Responses to Dexmethylphenidate Versus Methylphenidate. J Clin Psychopharmacol. 2015 Aug; 35(4):464-7.
    View in: PubMed
    Score: 0.027
  2. A double-blind placebo-controlled trial of N-acetylcysteine in the treatment of cocaine dependence. Am J Addict. 2013 Sep-Oct; 22(5):443-52.
    View in: PubMed
    Score: 0.023
  3. Effects of intravenous nicotine on prepulse inhibition in smokers and non-smokers: relationship with familial smoking. Psychopharmacology (Berl). 2013 Sep; 229(2):285-94.
    View in: PubMed
    Score: 0.023
  4. Differential influences of ethanol on early exposure to racemic methylphenidate compared with dexmethylphenidate in humans. Drug Metab Dispos. 2013 Jan; 41(1):197-205.
    View in: PubMed
    Score: 0.022
  5. The Obsessive Compulsive Cocaine Scale: assessment of factor structure, reliability, and validity. Addict Behav. 2011 Dec; 36(12):1223-7.
    View in: PubMed
    Score: 0.020
  6. Efficacy of a combination of flumazenil and gabapentin in the treatment of alcohol dependence: relationship to alcohol withdrawal symptoms. J Clin Psychopharmacol. 2009 Aug; 29(4):334-42.
    View in: PubMed
    Score: 0.018
  7. Measures of cognitive functioning as predictors of treatment outcome for cocaine dependence. J Subst Abuse Treat. 2009 Dec; 37(4):328-34.
    View in: PubMed
    Score: 0.017
  8. Is cocaine desire reduced by N-acetylcysteine? Am J Psychiatry. 2007 Jul; 164(7):1115-7.
    View in: PubMed
    Score: 0.015
  9. Self-reported sleep, sleepiness, and repeated alcohol withdrawals: a randomized, double blind, controlled comparison of lorazepam vs gabapentin. J Clin Sleep Med. 2007 Feb 15; 3(1):24-32.
    View in: PubMed
    Score: 0.015
  10. An open-label trial of N-acetylcysteine for the treatment of cocaine dependence: a pilot study. Prog Neuropsychopharmacol Biol Psychiatry. 2007 Mar 30; 31(2):389-94.
    View in: PubMed
    Score: 0.015
  11. A retrospective chart review comparing tiagabine and benzodiazepines for the treatment of alcohol withdrawal. J Psychoactive Drugs. 2005 Dec; 37(4):409-14.
    View in: PubMed
    Score: 0.014
  12. A controlled trial of amlodipine for cocaine dependence: a negative report. J Subst Abuse Treat. 2005 Mar; 28(2):197-204.
    View in: PubMed
    Score: 0.013
  13. Night eating syndrome: effects of brief relaxation training on stress, mood, hunger, and eating patterns. Int J Obes Relat Metab Disord. 2003 Aug; 27(8):970-8.
    View in: PubMed
    Score: 0.012
  14. Amlodipine reduces blood pressure and headache frequency in cocaine-dependent outpatients. J Psychoactive Drugs. 2002 Oct-Dec; 34(4):415-9.
    View in: PubMed
    Score: 0.011
  15. The differential effects of medication on mood, sleep disturbance, and work ability in outpatient alcohol detoxification. Am J Addict. 2002; 11(2):141-50.
    View in: PubMed
    Score: 0.010
  16. Divalproex loading in the treatment of cocaine dependence. J Psychoactive Drugs. 2001 Jul-Sep; 33(3):283-7.
    View in: PubMed
    Score: 0.010
  17. Gabapentin in the treatment of cocaine dependence: a case series. J Clin Psychiatry. 2001 Jan; 62(1):19-23.
    View in: PubMed
    Score: 0.010
  18. Adverse outcomes in a controlled trial of pergolide for cocaine dependence. J Addict Dis. 2001; 20(1):81-92.
    View in: PubMed
    Score: 0.010
  19. Multiple previous detoxifications are associated with less responsive treatment and heavier drinking during an index outpatient detoxification. Alcohol. 2000 Nov; 22(3):159-64.
    View in: PubMed
    Score: 0.010
  20. A double-blind, placebo-controlled outpatient trial of pergolide for cocaine dependence. Drug Alcohol Depend. 2000 Aug 01; 60(2):161-8.
    View in: PubMed
    Score: 0.009
  21. N-acetylcysteine for the treatment of comorbid alcohol use disorder and posttraumatic stress disorder: Design and methodology of a randomized clinical trial. Contemp Clin Trials. 2020 04; 91:105961.
    View in: PubMed
    Score: 0.009
  22. Divalproex in the treatment of alcohol withdrawal. Am J Drug Alcohol Abuse. 2000 Feb; 26(1):155-60.
    View in: PubMed
    Score: 0.009
  23. Recurrent detoxification may elevate alcohol craving as measured by the Obsessive Compulsive Drinking scale. Alcohol. 2000 Feb; 20(2):181-5.
    View in: PubMed
    Score: 0.009
  24. Changes in weight control behaviors and hedonic hunger in a commercial weight management program adapted for individuals with type 2 diabetes. Int J Obes (Lond). 2020 05; 44(5):990-998.
    View in: PubMed
    Score: 0.009
  25. Cardiac and mood-related changes during short-term abstinence from crack cocaine: the identification of possible withdrawal phenomena. Am J Drug Alcohol Abuse. 1999 Nov; 25(4):629-37.
    View in: PubMed
    Score: 0.009
  26. Amlodipine treatment of cocaine dependence. J Psychoactive Drugs. 1999 Apr-Jun; 31(2):117-20.
    View in: PubMed
    Score: 0.009
  27. Carbohydrate-deficient transferrin and alcohol use in medical examiner cases. Alcohol. 1999 Jan; 17(1):7-11.
    View in: PubMed
    Score: 0.008
  28. Characteristics of Weight Loss Trajectories in a Comprehensive Lifestyle Intervention. Obesity (Silver Spring). 2017 12; 25(12):2062-2067.
    View in: PubMed
    Score: 0.008
  29. Repetitive transcranial magnetic stimulation (rTMS) administration to heavy cannabis users. Am J Drug Alcohol Abuse. 2018; 44(1):47-55.
    View in: PubMed
    Score: 0.008
  30. Ethanol Interactions With Dexmethylphenidate and dl-Methylphenidate Spheroidal Oral Drug Absorption Systems in Healthy Volunteers. J Clin Psychopharmacol. 2017 Aug; 37(4):419-428.
    View in: PubMed
    Score: 0.008
  31. Impact on psychosocial outcomes of a nationally available weight management program tailored for individuals with type 2 diabetes: Results of a randomized controlled trial. J Diabetes Complications. 2017 May; 31(5):891-897.
    View in: PubMed
    Score: 0.007
  32. Oral cannabidiol does not produce a signal for abuse liability in frequent marijuana smokers. Drug Alcohol Depend. 2017 Mar 01; 172:9-13.
    View in: PubMed
    Score: 0.007
  33. A Double-Blind, Randomized, Controlled Pilot Trial of N-Acetylcysteine in Veterans With Posttraumatic Stress Disorder and Substance Use Disorders. J Clin Psychiatry. 2016 Nov; 77(11):e1439-e1446.
    View in: PubMed
    Score: 0.007
  34. Randomized controlled trial of a nationally available weight control program tailored for adults with type 2 diabetes. Obesity (Silver Spring). 2016 11; 24(11):2269-2277.
    View in: PubMed
    Score: 0.007
  35. Effects on cardiovascular risk factors of weight losses limited to 5-10. Transl Behav Med. 2016 09; 6(3):339-46.
    View in: PubMed
    Score: 0.007
  36. Pilot trial of gabapentin for the treatment of benzodiazepine abuse or dependence in methadone maintenance patients. Am J Drug Alcohol Abuse. 2016 05; 42(3):333-40.
    View in: PubMed
    Score: 0.007
  37. Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis. Neuropsychopharmacology. 2016 07; 41(8):1974-82.
    View in: PubMed
    Score: 0.007
  38. Features of cocaine dependence with concurrent alcohol abuse. Drug Alcohol Depend. 1995 Jul; 39(1):69-71.
    View in: PubMed
    Score: 0.007
  39. Neurocognitive status is associated with all-cause mortality among psychiatric, high-risk liver transplant candidates and recipients. Int J Psychiatry Med. 2015; 49(4):279-95.
    View in: PubMed
    Score: 0.007
  40. Emotional eating, marital status and history of physical abuse predict 2-year weight loss in weight loss surgery patients. Eat Behav. 2014 Dec; 15(4):619-24.
    View in: PubMed
    Score: 0.006
  41. Screening for current opioid misuse and associated risk factors among patients with chronic nonalcoholic pancreatitis pain. Pain Med. 2014 Aug; 15(8):1359-64.
    View in: PubMed
    Score: 0.006
  42. Changes in cardiovascular risk factors with participation in a 12-week weight loss trial using a commercial format. Eat Behav. 2014 Jan; 15(1):68-71.
    View in: PubMed
    Score: 0.006
  43. Types of benzodiazepines abused by chemically dependent inpatients. J Psychoactive Drugs. 1993 Oct-Dec; 25(4):315-9.
    View in: PubMed
    Score: 0.006
  44. Relations of hedonic hunger and behavioral change to weight loss among adults in a behavioral weight loss program utilizing meal-replacement products. Behav Modif. 2013 Nov; 37(6):790-805.
    View in: PubMed
    Score: 0.006
  45. Low frequency repetitive transcranial magnetic stimulation of the left dorsolateral prefrontal cortex transiently increases cue-induced craving for methamphetamine: a preliminary study. Drug Alcohol Depend. 2013 Dec 01; 133(2):641-6.
    View in: PubMed
    Score: 0.006
  46. Chronic pain among liver transplant candidates. Prog Transplant. 2012 Dec; 22(4):379-84.
    View in: PubMed
    Score: 0.006
  47. Race/ethnicity differences between alcohol, marijuana, and co-occurring alcohol and marijuana use disorders and their association with public health and social problems using a national sample. Am J Addict. 2012 Sep-Oct; 21(5):435-44.
    View in: PubMed
    Score: 0.005
  48. Profiles of hospitalized benzodiazepine abusers. J Psychoactive Drugs. 1991 Jan-Mar; 23(1):71-2.
    View in: PubMed
    Score: 0.005
  49. Pergolide mesylate treatment of cocaine withdrawal. J Clin Psychiatry. 1991 Jan; 52(1):39-40.
    View in: PubMed
    Score: 0.005
  50. Distinctive characteristics of methamphetamine users presenting at public clinics: steep rise in South Carolina, United States, 2000-2005. Drug Alcohol Depend. 2011 May 01; 115(1-2):9-15.
    View in: PubMed
    Score: 0.005
  51. A piece of my mind. Little battles. JAMA. 1990 Jan 05; 263(1):90.
    View in: PubMed
    Score: 0.005
  52. Patterns of illegal drug use among an adult alcohol dependent population: results from the National Survey on Drug Use and Health. Drug Alcohol Depend. 2010 Jan 15; 106(2-3):119-25.
    View in: PubMed
    Score: 0.004
  53. Depression and bulimia: the link between depression and bulimic cognitions. J Abnorm Psychol. 1989 Aug; 98(3):322-5.
    View in: PubMed
    Score: 0.004
  54. A double-blind trial of gabapentin versus lorazepam in the treatment of alcohol withdrawal. Alcohol Clin Exp Res. 2009 Sep; 33(9):1582-8.
    View in: PubMed
    Score: 0.004
  55. Application of behavioral principles in the management of suffocation phobia: a case study of chronic respiratory failure. Int J Psychiatry Med. 1989; 19(3):281-9.
    View in: PubMed
    Score: 0.004
  56. The role of cystine-glutamate exchange in nicotine dependence in rats and humans. Biol Psychiatry. 2009 May 15; 65(10):841-5.
    View in: PubMed
    Score: 0.004
  57. Differences between adult non-drug users versus alcohol, cocaine and concurrent alcohol and cocaine problem users. Addict Behav. 2009 Mar; 34(3):323-6.
    View in: PubMed
    Score: 0.004
  58. Remission of metabolic syndrome following a 15-week low-calorie lifestyle change program for weight loss. Int J Obes (Lond). 2009 Jan; 33(1):144-50.
    View in: PubMed
    Score: 0.004
  59. Idiosyncratic reaction to naltrexone augmented by thioridazine. Am J Psychiatry. 1988 Jun; 145(6):773-4.
    View in: PubMed
    Score: 0.004
  60. Two CES1 gene mutations lead to dysfunctional carboxylesterase 1 activity in man: clinical significance and molecular basis. Am J Hum Genet. 2008 Jun; 82(6):1241-8.
    View in: PubMed
    Score: 0.004
  61. Adolescents with insomnia and substance abuse: consequences and comorbidities. J Psychiatr Pract. 2008 May; 14(3):146-53.
    View in: PubMed
    Score: 0.004
  62. Acquired immune deficiency syndrome: psychological impact on health personnel. J Nerv Ment Dis. 1987 Aug; 175(8):496-9.
    View in: PubMed
    Score: 0.004
  63. Buprenorphine for postoperative pain following general surgery in a buprenorphine-maintained patient. Am J Psychiatry. 2007 Jun; 164(6):979.
    View in: PubMed
    Score: 0.004
  64. Naltrexone and dysphoria: a double-blind placebo controlled trial. Biol Psychiatry. 1987 Jun; 22(6):710-6.
    View in: PubMed
    Score: 0.004
  65. Influence of ethanol and gender on methylphenidate pharmacokinetics and pharmacodynamics. Clin Pharmacol Ther. 2007 Mar; 81(3):346-53.
    View in: PubMed
    Score: 0.004
  66. Characteristics of cocaine- and marijuana-dependent subjects presenting for medication treatment trials. Addict Behav. 2007 Jul; 32(7):1433-40.
    View in: PubMed
    Score: 0.004
  67. Silver acetate gum as a deterrent to smoking. Chest. 1986 Jul; 90(1):107-11.
    View in: PubMed
    Score: 0.004
  68. Pharmacokinetics of olanzapine after single-dose oral administration of standard tablet versus normal and sublingual administration of an orally disintegrating tablet in normal volunteers. J Clin Pharmacol. 2006 Feb; 46(2):164-71.
    View in: PubMed
    Score: 0.003
  69. Safety and tolerability of N-acetylcysteine in cocaine-dependent individuals. Am J Addict. 2006 Jan-Feb; 15(1):105-10.
    View in: PubMed
    Score: 0.003
  70. A controlled trial of naltrexone in obese humans. Int J Obes. 1985; 9(5):347-53.
    View in: PubMed
    Score: 0.003
  71. Modafinil influences the pharmacokinetics of intravenous cocaine in healthy cocaine-dependent volunteers. Clin Pharmacokinet. 2005; 44(7):753-65.
    View in: PubMed
    Score: 0.003
  72. Insomnia and its treatment. When are hypnotics justified? Postgrad Med. 1984 Jul; 76(1):83-90.
    View in: PubMed
    Score: 0.003
  73. Family-focused smoking cessation:enhanced efficacy by the addition of partner support and group therapy. Subst Abus. 2004 Mar; 25(1):37-41.
    View in: PubMed
    Score: 0.003
  74. Effects of sustained-release bupropion among persons interested in reducing but not quitting smoking. Am J Med. 2004 Feb 01; 116(3):151-7.
    View in: PubMed
    Score: 0.003
  75. Carbamazepine in the treatment of cocaine dependence: subtyping by affective disorder. Exp Clin Psychopharmacol. 2002 Aug; 10(3):276-85.
    View in: PubMed
    Score: 0.003
  76. Psychosocial aspects of total parenteral nutrition. Psychosomatics. 1980 Feb; 21(2):115-25.
    View in: PubMed
    Score: 0.002
  77. Taste hedonics and thresholds in obesity. Int J Obes. 1980; 4(3):203-12.
    View in: PubMed
    Score: 0.002
  78. Behavioral techniques in the psychological rehabilitation of burn patients. Int J Psychiatry Med. 1980-1981; 10(2):145-50.
    View in: PubMed
    Score: 0.002
  79. Naltrexone and cognitive behavioral therapy for the treatment of outpatient alcoholics: results of a placebo-controlled trial. Am J Psychiatry. 1999 Nov; 156(11):1758-64.
    View in: PubMed
    Score: 0.002
  80. Pancytopenia associated with varicella. Br J Clin Pract. 1979 Oct; 33(10):299-300.
    View in: PubMed
    Score: 0.002
  81. Multiple previous alcohol detoxifications are associated with decreased medial temporal and paralimbic function in the postwithdrawal period. Alcohol Clin Exp Res. 1999 Jun; 23(6):1077-84.
    View in: PubMed
    Score: 0.002
  82. Gabapentin treatment of alcohol withdrawal. Am J Psychiatry. 1998 Nov; 155(11):1632.
    View in: PubMed
    Score: 0.002
  83. The role of weight control as a motivation for cocaine abuse. Addict Behav. 1998 Mar-Apr; 23(2):201-7.
    View in: PubMed
    Score: 0.002
  84. Pergolide mesylate. Adverse events occurring in the treatment of cocaine dependence. Am J Addict. 1997; 6(2):117-23.
    View in: PubMed
    Score: 0.002
  85. Naltrexone treatment of self-injurious thoughts and behaviors. J Nerv Ment Dis. 1996 Mar; 184(3):192-5.
    View in: PubMed
    Score: 0.002
  86. Cocaine-induced psychosis. J Clin Psychiatry. 1991 Dec; 52(12):509-12.
    View in: PubMed
    Score: 0.001
  87. Substance abuse in an inpatient psychiatric sample. Am J Drug Alcohol Abuse. 1991; 17(4):389-97.
    View in: PubMed
    Score: 0.001
  88. Abuse of caffeine in substance abusers. J Clin Psychiatry. 1988 Nov; 49(11):457.
    View in: PubMed
    Score: 0.001
  89. Alcohol detoxification and withdrawal seizures: clinical support for a kindling hypothesis. Biol Psychiatry. 1988 Mar 01; 23(5):507-14.
    View in: PubMed
    Score: 0.001
  90. Treatment of insomnia in cancer patients using muscle relaxation training. J Behav Ther Exp Psychiatry. 1983 Sep; 14(3):251-6.
    View in: PubMed
    Score: 0.001
  91. Psychosocial and developmental factors in failure to thrive: one- to three- year follow-up. J Dev Behav Pediatr. 1981 Sep; 2(3):112-4.
    View in: PubMed
    Score: 0.001
  92. Restraint and age at onset of obesity. Addict Behav. 1981; 6(2):135-8.
    View in: PubMed
    Score: 0.001
  93. Experienced control and participation in treatment of obesity. Psychol Rep. 1980 Dec; 47(3 Pt 2):1127-34.
    View in: PubMed
    Score: 0.001
  94. Effects of sex of subject and spouse involvement on weight loss in a behavioral treatment program: a retrospective investigation. Addict Behav. 1979; 4(2):167-77.
    View in: PubMed
    Score: 0.001
  95. Behavioral treatment of obesity. Limitations and results with the chronically obese. JAMA. 1977 Jun 27; 237(26):2829-31.
    View in: PubMed
    Score: 0.000
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.